FOA-treatment increases RNR expression in dot1Δ and cac1Δ cells, but not lrs4Δ cells, and CDC21 overexpression or HU treatment restores 5FOA resistance to dot1Δ and cac1Δ cells, but not lrs4Δ cells. (A) RNR4 transcript levels (normalized to ACT1) as measured by quantitative reverse transcriptase PCR (qRT-PCR) following a 4-h treatment with 5FOA or DMSO. Error bars represent the SEM for three independent experiments. WT, wild-type. Strains: KMY368, KMY1391, KMY1465, KMY74, KMY59. (B) Expression levels of RNR4 (normalized to ACT1) measured by qRT-PCR following a 4-h treatment with 5FOA with or without HU. Error bars represent the SEM for two independent experiments. WT, wild-type. Strains: KMY368, KMY1391, KMY1465. (C) Schematic showing impact of 5FOA on RNR in dot1Δ or cac1Δ cells (top). Serial dilutions of cells with the URA3 reporter gene inserted proximal to telomere VII-L were plated on synthetic complete (SC) medium, medium lacking leucine (−LEU), or medium lacking leucine, and supplemented with 5FOA (−LEU + 5FOA; bottom). All cells were spotted on the same corresponding plates. WT, wild-type. Strains: KMY368, KMY1391, KMY1465, KMY74. (D) URA3-TELVII-L transcript levels (normalized to ACT1) as measured by qRT-PCR. Error bars represent the SEM for three independent runs. WT, wild-type. Strains: KMY1565, KMY1567, KMY1568.